In a range of pathophysiological situations, such as obesity, type 2 diabetes, and other metabolic abnormalities, ghrelin concentrations have been demonstrated to be lowered (Barazzoni et al., 2007; Poykko et al., 2003). This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.